Bayesian Causal Inference for Cancer Mutational Signatures

IN PROGRESS
mutational signatures
causal inference
bayesian computation
genomics
Author

Jenna Landy

Published

May 1, 2023

Mutational signatures analysis is a quickly growing field to model mutational processes in tumor genomes. Computationally-derived mutational signatures have been associated with known mutational pathways, including DNA damage repair deficiencies (Jeong et al. 2021) and deamination of 5-methylcytosine (Nik-Zainal et al. 2012), as well as known carcinogens, including tobacco smoking and ultraviolet radiation (Pfeifer 2010). This new way to characterize tumors has the potential to uncover yet unidentified mutational processes.

We are looking at mutational signatures through the lens of causal inference to answer questions about the causal effects of such exposures on the presence and magnitude of mutational signatures in cancer genomes. Using mutational signatures (or any latent factor) as an outcome in the causal inference framework comes with many challenges.


Advised by Giovanni Parmigiani, PhD and Nima Hejazi, PhD
Department of Data Science, Dana Farber Cancer Institute
Department of Biostatistics, Harvard T.H. Chan School of Public Health